European PostASCO Meeting 2011

Transcription

1 European PostASCO Meeting 2011 Course Directors Axel Hauschild, MD Claus Garbe, MD Interdisciplinary Global Conference on Developing New Treatments for Melanoma Second announcement July 7 th 8 th, 2011 Munich, Germany Leonardo Royal Hotel E A D O Under the auspices of the European Association of Dermato-Oncology and ADO/DeCOG

2 Foreword Dear colleagues and friends, metastatic melanoma is still considered as a disease that is extremely hard to treat. It shows a dismal prognosis and mainly effects middle-aged women and men. The current treatment options apart from clinical trial participation are very limited. New treatment modalities for this disease have not been approved for decades. However, we are expecting a significant improvement of the treatment options for melanoma in the near future. Numerous new therapies are emerging for the adjuvant treatment of high-risk melanoma patients, such as for non-resectable metastatic melanoma patients. New immunotherapeutic and targeted agents will be used either apart, or in combination. In addition to conventional chemotherapy, intralesional and loco-regional treatment methods are still of important value. However, it will be the main target for all of us to choose the right patients for the right drugs! The aim of the Interdisciplinary Global Conference on Developing New Treatments for Melanoma in Munich is to grant a deep overall insight into the development of new drugs for melanoma. The lively interaction of clinicians, as well as experts in translational and basic research, and representatives of the pharmaceutical industry, guarantees a successful outcome for every participant. International key opinion leaders will be invited to give an overview throughout specified presentations, to present latest clinical trial results, and to discuss on exciting new drugs with the audience at roundtables. In addition to the scientific value of this meeting, every participant may seize the given opportunity to interact with experts in a familiar setting in one of the most interesting cities of Germany. Please join us for this melanoma event and submit your own studies and case presentations as free communications and as posters. We look forward to welcoming you in Munich in July 2011! Axel Hauschild, MD Conference President Claus Garbe, MD Conference President 3

3 Thursday, July 7 th 4 8:00 12:00 Pre-congress time slots for study/advisory meetings 12:00 Opening of the Conference EADO Presidential Address Jean-Jacques Grob, Marseille, France 12:10 14:00 SYMPOSIUM I Melanoma classification for treatment decisions Chairpersons: Jean-Jacques Grob, Marseille, France Hubert Pehamberger, Vienna, Austria 12:10 12:28 AJCC classification: New indications for treatment decisions? Vernon Sondak, Tampa, USA 12:32 12:50 Assessment and reproducibility of ulceration and mitotic rate Rudolf Stadler, Minden, Germany 12:54 13:12 Molecular classification of melanoma: ready for prime time? Dirk Schadendorf, Essen, Germany 13:16 13:34 Biomarkers for interferon responsiveness Helen Gogas, Athens, Greece 13:38 13:56 Proliferation versus invasion: what is driving melanoma progression? Reinhard Dummer, Zurich, Switzerland 14:00 14:30 COFFEE BREAK 14:30 15:30 SATELLITE SYMPOSIUM I (MSD) What s your opinion about adjuvant melanoma treatment? An interactive symposium. Chairperson: Axel Hauschild, Kiel, Germany 14:30 14:46 Update on SLND and selecting patients for adjuvant therapy Vernon Sondak, Tampa, USA 14:50 15:06 Rationale for current and new adjuvant treatment modalities: pegylated IFN, high-dose IFN, ipilimumab, MAGE-A3 ASCI or combinations? John Kirkwood, Pittsburgh, USA 15:10 15:26 Case presentations/interactive questions and answers Axel Hauschild, Kiel, Germany 15:30 16:00 KEY NOTE LECTURE Chairpersons: Friedegund Meier, Tuebingen, Germany Alexander Stratigos, Athens, Greece 15:30 16:00 Update on melanoma stem cells Meenhard Herlyn, Philadelphia, USA

4 Thursday, July 7 th 16:00 17:00 SYMPOSIUM II Panel Discussion: Gene mutation testing and reimbursement issues Chairpersons: Alexander Enk, Heidelberg, germany Andreas Mackensen, Erlangen, germany 16:00 16:12 What can we learn from molecular testing of lung cancer? Reinhard Büttner, Bonn, Germany 16:15 16:27 Gene mutation testing: How I do it Jürgen Bauer, Tuebingen, Germany 16:30 16:42 BRAF Jeffrey Lawrence, Pleasanton, USA 16:45 16:57 c-kit Carola Berking, Munich, Germany 16:00 18:00 Free Communications r1+r2 Chairpersons: Helen Gogas, Athens, Greece Josep Malvehy, Barcelona, Spain 17:00 18:00 SATELLITE SYMPOSIUM II (Roche) Chairperson: Axel Hauschild, Kiel, Germany 17:00 17:16 Hedgehog pathway inhibition as a new therapeutic approach in cancer Caroline Robert, Paris, France 17:20 17:36 Vismodegib in basal cell carcinoma Dirk Schadendorf, Essen, Germany 17:40 17:56 Patient cases Axel Hauschild, Kiel, Germany 18:00 19:00 SATELLITE SYMPOSIUM III r1+r2 (Swedish Orphan Biovitrum AB) Interferon-alpha in Melanoma New Approaches Chairperson: Rudolf Stadler, Minden, Germany 18:00 18:25 Biology of human multiple subtypes of interferon-alpha Eric Lundgren, Umea, Sweden 18:30 18:55 The neoadjuvant approach and the ongoing Multiferon trial Claus Garbe, Tuebingen, Germany 18:00 19:00 GUIDED POSTER TOUR 20:00 GET TOGETHER DINNER in a Typical Bavarian beer garden 5

5 Friday, July 8 th 8:00 10:00 SYMPOSIUM III New Treatment Developments for Melanoma Chairpersons: Roland Kaufmann, Frankfurt, germany lev Demidov, MoscoW, Russia 08:00 08:10 Pegylated interferon-α2b (PegIntron ) Poulam Patel, Nottingham, UK 08:12 08:22 Natural interferon-α (Multiferon ) Uwe Trefzer, Berlin, Germany 08:24 08:34 Selumetinib (AZD6244) Reinhard Dummer, Zurich, Switzerland 08:36 08:46 GM-CSF John M. Kirkwood, Pittsburg, USA 08:48 08:58 OncoVex GM-CSF Robert Coffin, Woburn, USA 09:00 09:10 Tasisulam Peter Mohr, Buxtehude, Germany 09:12 09:22 Multi-VEGF inhibitor (E7080) Keith Flaherty, Boston, USA 09:24 09:34 nab-paclitaxel (Abraxane ) Axel Hauschild, Kiel, Germany 09:36 09:46 Allovectin-7 Sanjiv S. Agarwala, Bethlehem, USA 09:48 09:58 High Dose Regional Melphalan for Liver Mets James Pingpank, Pittsburgh, USA 10:00 10:15 COFFEE BREAK 10:15 11:15 SATELLITE SYMPOSIUM IV (BMS) The therapeutic landscape of advanced melanoma: recent developments and clinical implications Chairperson: Michele Maio, Siena, Italy 10:15 10:20 Welcome and introductions 10:20 10:36 The changing standard of care for patients with advanced melanoma Axel Hauschild, Kiel, Germany 10:40 10:56 How will emerging therapies influence our treatment practices and patient management? Paul Lorigan, Manchester, UK 11:00 11:15 Questions & Answers 6

6 Friday, July 8 th 11:15 11:45 KEY NOTE LECTURE Chairperson: Alan Spatz, Montreal, Canada 11:15 11:45 When does the presence of a target lead to treatment response? Keith Flaherty, Boston, USA 11:45 12:00 COFFEE BREAK 12:00 13:00 SATELLITE SYMPOSIUM V (Roche) (with lunch) Chairperson: Axel Hauschild, Kiel, Germany 12:00 12:16 Vemurafenib,a specific mutant B-Raf inhibitor: Mechanisms of action and result from BRIM 1 and 2 Keith Flaherty, Boston, USA 12:20 12:36 First results of the prospective-randomized phase III trial on Vemurafenib versus DTIC (BRIM-3) Axel Hauschild, Kiel, Germany 12:40 12:56 Management of cutaneous adverse events related to Vemurafenib Caroline Robert, Paris, France 13:00 15:00 SYMPOSIUM IV New Treatment Developments for Melanoma Chairpersons: Ketty Peris, l Aquila, Italy somasundaram Subramanian, MoscoW, Russia 13:00 13:10 RG7204 (PLX4032) Keith Flaherty, Boston, USA 13:12 13:22 Ipilimumab Caroline Robert, Paris, France 13:24 13:34 Bevacizumab Paul Lorigan, Manchester, UK 13:36 13:46 Imatinib/Nilotinib Jun Guo, Beijing, China 13:48 13:58 Masitinib Alain Moussy, Paris, France 14:00 14:10 MAGE-3 ASCI Brigitte Dreno, Nantes, France 14:12 14:22 Recombinant IL-21 Teresa Petrella, Toronto, Canada 14:24 14:34 Adoptive T-cell transfer Jacob Schachter, Tel Aviv, Israel 14:36 14:46 Electrochemotherapy Alessandro Testori, Milan, Italy 14:48 14:58 CAVATAK Darren Shafren, Newcastle, Australia 7

7 Friday, July 8 th 15:05 16:00 SYMPOSIUM V (roundtable discussion) What are the most promising combinations for the future? Chairpersons: Enrique Espinosa, Madrid, Spain Piotr Rutkowski, Warsaw, Poland 15:05 15:13 BRAF and MEK resistance Friedegund Meier, Tuebingen, Germany 15:15 15:23 Combining MAP kinase and AKT inhibition Jürgen Becker, Graz, Austria 15:25 15:33 Immunotherapy combinations Peter Hersey, Newcastle, Australia 15:35 16:00 roundtable Discussion Discussants: Jürgen Becker, Graz, Austria; Keith Flaherty, Boston, USA; Claus Garbe, Tuebingen, Germany; Peter Hersey, Newcastle, Australia; Friedegund Meier, Tuebingen, Germany; Alberto Wainstein, Belo Horizonte, Brazil 16:00 16:30 COFFEE BREAK 16:30 17:30 SATELLITE SYMPOSIUM VI (Philogen) Darleukin in Melanoma New Data CHAIRPERSON: CLAUS GARBE, TueBINGEN, GERMANY 16:30 16:46 The tumor-targeting human L19-IL2 immunocytokine Eveline Trachsel, Otelfingen, Switzerland 16:50 17:06 L19-IL2 and dacarbazine in stage IV metastatic melanoma Thomas K. Eigentler, Tuebingen, Germany 17:10 17:26 Intratumoral L19-IL2 in cutaneous melanoma metastases Benjamin Weide, Tuebingen, Germany 8

8 Friday, July 8 th 16:30 17:30 SYMPOSIUM VI r1+r2 Cutaneous adverse events of new anticancer drugs Chairpersons: Caroline Robert, Paris, France Judith Oláh, Szeged, Hungary 16:30 16:46 EGFR inhibitors Caroline Robert, Paris, France 16:50 17:06 Braf and MEK inhibitors Katharina C. Kähler, Kiel, Germany 17:10 17:26 Chemotherapeutic drugs Ralf Gutzmer, Hannover, Germany 17:30 18:00 KEY NOTE LECTURE Chairperson: Lars Bastholt, Odense, Denmark 17:30 18:00 How I will treat melanoma in 2015 Alexander Eggermont, Paris, France 18:00 Mini-Symposia/Time slots for advisory boards 9

9 Congress faculty Sanjiv S. Agarwala, MD Chief, Department of Oncology St. Luke s Cancer Center 801 Ostrum St Bethlehem, PA , USA Phone: AgarwaS@slhn.org Lars Bastholt, MD Odense University Hospital Sdr. Boulevard Odense, Denmark Phone: lars.bastholt@ouh.fyns-amt.dk Jürgen Bauer, MD Eberhard Karls University Liebermeister Straße Tuebingen, Germany Phone: juergen.bauer@med. uni-tuebingen.de Jürgen Becker, MD Medical University of Graz Auenbruggerplatz Graz, Austria Phone: juergen.becker@meduni-graz.at Carola Berking, MD Ludwig Maximilians University Frauenlobstraße Munich, Germany Phone: carola.berking@med.uni-muenchen.de Reinhard Büttner, MD Professor of Pathology Department of Pathology University Hospital Bonn Sigmund-Freud-Straße Bonn, Germany Phone: Reinhard.Buettner@ukb.uni-bonn.de Robert Coffin, MD Chief Technology Officer and Director BioVex 34 Commerce Way Woburn, MA 01801, USA Phone: RCoffin@biovex.com Lev Demidov, MD Professor of Biotherapy Russian Academy of Medical Sciences Blokhin Cancer Center Kashirskoye Shosse Moscow, Russia Phone: demidov.lev@gmail.com Brigitte Dreno, MD University of Nantes CHU Nantes Place Alexis Ricordeau Cedex 01, France Phone: brigitte.dreno@wanadoo.fr Reinhard Dummer, MD Universitätsspital Zurich Gloriastrasse 31 CH-8091 Zurich, Switzerland Phone: reinhard.dummer@usz.ch Alexander M. M. Eggermont, MD, PhD Professor of Surgery Directeur Général, Institut de Cancérologie Gustave Roussy 114 Rue Edouard Vaillant Villejuif/Paris, France Phone: alexander.eggermont@igr.fr Thomas Eigentler, MD Eberhard Karls University Liebermeister Straße Tuebingen, Germany Phone: thomas.eigentler@med. uni-tuebingen.de Alexander Enk, MD Director, University of Heidelberg Voßstraße Heidelberg, Germany Phone: alexander.enk@med.uni-heidelberg.de Enrique Espinosa, MD Hospital La Paz Paseo Castellana 261 Madrid 28046, Spain Phone: eespinosa00@terra.es Keith T. Flaherty, MD Director, Developmental Theraupeutics Massachusetts General Hospital Cancer Center 55 Fruit Street, Yawkey 9E Boston, MA 02114, USA Phone: kflaherty@partners.org 10

10 Congress faculty Claus Garbe, MD Eberhard Karls University Liebermeister Straße Tuebingen, Germany Phone: uni-tuebingen.de Helen Gogas, MD Medical School, University of Athens 24 Karneadou STR Athens 10675, Greece Phone: Jean-Jacques Grob, MD Service de Dermatologie Hopital Ste Marguerite 270 Av Ste Marguerite Marseille Cedex 09, France Phone: Jun Guo, MD Dept. Melanoma & Renal cancer Peking University School of Oncology Beijing Cancer Hospital & Research 52# Fucheng Rd, Haidian District Beijing, China Phone: Ralf Gutzmer, MD Dept. of Dermatology Hannover Medical School Hauttumorzentrum Recklingerstraße Hannover, Germany Phone: rgutzmer@gmx.de Axel Hauschild, MD University of Kiel Schittenhelmstraße Kiel, Germany Phone: ahauschild@dermatology.uni-kiel.de Meenhard Herlyn, MD Associate Director for Translational Research Wistar Institute Cancer Center 3601 Spruce St. Philadelphia, PA 19104, USA Phone: herlynm@wistar.org Peter Hersey, MD Department of Oncology Room 443 Newcastle University David Madison Building Cnr King And Watt Sts Newcastle NSW 2300, Australia Phone: Peter.Hersey@Newcastle.edu.au Katharina C. Kähler, MD University of Kiel Schittenhelmstraße Kiel, Germany Phone : kckaehler@yahoo.de Roland Kaufmann, MD, Director Clinical Center J. W. Goethe University Theodor-Stern-Kai Frankfurt/Main, Germany Phone: kaufmann@em.uni-frankfurt.de John M. Kirkwood, MD Usher Professor of Medicine and Dermatology University of Pittsburgh School of Medicine Director, Melanoma and Skin Cancer Program University of Pittsburgh Cancer Institute Hillman Research Suite L1.32c 5115 Centre Avenue Pittsburgh PA , USA Phone: KirkwoodJM@upmc.edu H. Jeffrey Lawrence, MD Senior Director, Medical & Scientific Affairs Genomics & Oncology Roche Molecular Systems, Inc Hacienda Drive Pleasanton, CA 94588, USA Phone: jeffrey.lawrence@roche.com Paul Lorigan, MD, FRCP Senior Lecturer and Consultant in Medical Oncology School of Cancer and Imaging Sciences University of Manchester c/o The Christie NHS Foundation Trust Wilmslow Road, Withington Manchester M20 4BX, UK Phone: paul.lorigan@christie.nhs.uk Erik Lundgren, MD, PhD Professor of Molecular Biology University of Umea Umea, Sweden S Phone: erik.lundgren@molbiol.umu.se 11

11 Congress faculty Andreas Mackensen, MD Director, Department of Medical Oncology Universitätsklinikum Erlangen Medizinische Klinik 5 Hämatologie und Internistische Onkologie Krankenhausstr Erlangen, Germany Phone: andreas.mackensen@uk-erlangen.de Michele Maio, MD Department of Oncology University Hospital of Siena Strada delle Scotte n Siena, Italy Phone: mmaio@cro.it Josep Malvehy, MD Coordinator of the Melanoma Unit Hospital Clínico de Barcelona C/Villarroel Barcelona, Spain Phone: JMALVEHY@clinic.ub.es Friedegund Meier, MD Eberhard Karls University Liebermeister Straße Tuebingen, Germany Phone: friedegund.meier@t-online.de Peter Mohr, MD Center of Dermatology Elbeklinikum Buxtehude Am Krankenhaus Buxtehude, Germany Phone: / Peter.Mohr@elbekliniken.de Alain Moussy, MD CEO, AB Science 3, av George V Paris, France Phone : a.moussy@ab-science.com Judith Oláh, MD and Allergology University of Szeged 6720 Szeged, Hungary oj@derma.szote.u-szeged.hu Poulam Patel, MD Nottingham University Hospitals City Campus Hucknell Road, Nottingham NG51PB UK Phone: poulam.patel@nottingham.ac.uk Hubert Pehamberger, MD Director, University of Vienna Währinger Gürtel Vienna, Austria Phone: hubert.pehamberger@ meduniwien.ac.at Ketty Peris, MD University of L Aquila Via Vetoio - Coppito L Aquila, Italy Phone: peris@univaq.it Teresa Petrella, MD Odette Cancer Center University of Toronto 2075 Bayview Ave Toronto, Ontario M4N-3M5, Canada Phone: Teresa.petrella@sunnybrook.ca James Pingpank, MD Professor of Surgery Division of Surgical Oncology University of Pittsburgh Physicians Hillman Cancer Center 5150 Centre Avenue Pittsburgh, PA 15232, USA Phone: PingpankJF@UPMC.edu Caroline Robert, MD Head of the Dermatology Unit Institute Gustave Roussy 39 rue Camille Desmoulins Villejuif Cedex, France Phone: caroline.robert@igr.fr Piotr Rutkowski, MD Director, Department of Soft Tissue/Bone Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland rutkowskip@coi.waw.pl Jacob Schachter, MD Sheba Medical Center Head Ella Institute for Melanoma Deputy Director Division of Oncology Tel Hashomer Israel Phone: Jacob.Schachter@sheba. health.gov.il 12

12 Congress faculty Dirk Schadendorf, MD Director, University Hospital Essen Hufelandstraße Essen, Germany Phone: Darren Shafren, MD Chief Scientific Officer Viralytics Limited. Level 3, David Maddison Building Cnr King and Watt Sts Newcastle 2300, NSW Australia Phone: dshafren@mail.newcastle.edu.au Vernon Sondak, MD Professor of Surgery Chief, Division of Cutaneous Oncology Director of Surgical Education H. Lee Moffitt Cancer Center and Research Institute Magnolia Drive Tampa FL 33612, USA Phone: Vernon.Sondak@moffitt.org Alan Spatz, MD Professor of Pathology and Oncology Department of Pathology Jewish General Hospital McGill University 3755 Côte Ste Catherine Road Montreal, Quebec H3T 1E2, Canada Phone: X alan.spatz@mcgill.ca Rudolf Stadler, MD Director, Medical Center Minden Hans-Nolte-Straße Minden, Germany Phone: hautklinik@klinikum-minden.de Alexander Stratigos, MD University of Athens 28 Voucourestiou Street Athens 10671, Greece Phone: alstrat@hol.gr Somasundaram Subramanian, MD Director, Eurasian Oncology Program The Russian Academy of Medical Sciences 24, Kashirshoye Shosse Moscow, Russia Phone: drsoma@gmail.com Alessandro Testori, MD Director Melanoma and muscle-cutaneous sarcomas Division Istituto Europeo di Oncologia Via Ripamonti Milan, Italy Phone: alessandro.testori@ieo.it Eveline Trachsel, MD Head of therapeutic antibody research Philochem AG Industriestrasse Otelfingen, Switzerland Phone: eveline.trachsel@philochem.ch Uwe Trefzer, MD Charité Berlin Skin Cancer Center Charité Charitéplatz Berlin, Germany Phone: uwe.trefzer@charite.de Alberto Wainstein, MD Biocancer Clinical Research Rua Amapa 3616 Belo-Horizonte, Minas Gerais Brazil Phone: alberto@biocancer.com.br Benjamin Weide, MD Dept. of Dermatology Eberhard Karls University Liebermeister Straße Tuebingen, Germany Phone: benjamin.weide@med. uni-tuebingen.de 13

13 General information Congress Venue Leonardo Royal Hotel Munich, Moosacher Straße 90, München Date: July 7 8, 2011 Congress Organization Mrs. Mirja Christ from MedConcept is the responsible congress organizer. Contact: MedConcept, Gesellschaft für medizinische Projekte mbh, August-Borsig-Ring 37, Schöneiche bei Berlin, Germany, Phone: , Fax: , info@medconcept.org or mirja.christ@medconcept.org, Hotel Accommodation Individual hotel reservation: Please contact the congress hotel or one of the hotels nearby directly for your individual room bookings. MedConcept has reserved a limited number of rooms under the reference Global Meeting 2011 in the following hotels: Leonardo Royal Hotel Munich Moosacher Str. 90, Munich Phone: +49 (0) , Fax: +49 (0) , info.royalmunich@leonardo-hotels.com Rate per standard room and night: 129 E single and 149 E double, breakfast included Booking deadline: May 28, 2011 NH München Deutscher Kaiser Arnulfstr. 2, Munich Phone: +49 (0) , Fax: +49 (0) , nhdeutscherkaiser@nh-hotels.com Rate per standard room and night: 150 E single and 171 E double, breakfast included Booking deadline: May 11, 2011 Distance to Leonardo Royal Hotel: 8 km Eden Hotel Wolff Arnulfstr. 4, Munich Phone: +49 (0) , Fax: + 49 (0) , info@ehw.de Rate per standard room and night: 129 E single and 165 E double, breakfast included Booking deadline: June 9, 2011 Distance to Leonardo Royal Hotel: 6 km Four Points By Sheraton München Olympiapark Helene-Meyer-Ring 12, Munich Phone: +49 (0) , Fax: +49 (0) , olympiaparkmuenchen@fourpoints.com Rate per standard room and night: 109 E single and 128 E double, breakfast included Booking deadline: May 25, 2011 Distance to Leonardo Royal Hotel: 1 km All booking of rooms only according to availability! All rates include 19 % VAT! 14

14 General information Language and translation The official language of the meeting will be English. Simultaneous translation will not be provided. Exhibition A Commercial Exhibition will be held at the Congress Venue, close to the main meeting rooms. If you are interested in participating as an exhibitor, please contact MedConcept s secretariat for further information. Fees (VAT included) Early registration: till May 6 th From May 7 th till June 24 th On site Full Delegates 300 Euro 400 Euro 500 Euro Residents (doctor-in-training) 200 Euro 250 Euro 300 Euro Eastern European Countries 200 Euro 250 Euro 300 Euro Day Ticket July 7 th July 8 th 150 Euro 200 Euro 250 Euro If more than one member of the same institution registers a special early registration fee of 250 Euro per person (Full Delegates) and 150 Euro per person (Residents and Eastern European Countries) will be honored for all participants belonging to this institution. This offer is only valid if participants can proof that multiple members of this institution have registered. Should our sponsors wish to purchase 10 tickets or more we would like to offer a special discount. Please contact us for further information. Get-Together Dinner In a typical Bavarian beer garden July 7th, 2011, 20:00 h Augustiner Keller, Arnulfstr. 52, Munich Phone +49 (0) , This informal get-together will be the perfect opportunity to meet and socialize with other delegates. Beverages and a typical Bavarian buffet will be provided. Transportation will be provided from the Leonardo Royal Hotel to the Augustiner Keller at 19:30h and 19:45h. Transportation back to the Leonardo Royal Hotel will be at 22:30 h, 23:30 h and 00:30 h. Price per person: 50 Euro incl. VAT (Please note that the number of tickets is limited.) 15

15 General information Cancellation policy Cancellations must be received in writing by July 1, No refunds will be granted after that date; however, you may transfer your registration to a colleague. An administrative fee of 30 Euro will be assessed for cancellations received at any time. The participant acknowledges that he/she has no right to lodge damage claims against the organizers should the holding of the meeting be hindered or prevented by unexpected, political or economic events or generally by force, or should the non-appearance of speakers or other reasons need program changes. With registration, the participant accepts this proviso. Insurance The Organizer does not accept liability for individual medical, travel or personal insurance and participants are strongly advised to make their own arrangements in respect to health and travel insurance. Passport and visa For most nationalities visas are not required for entering Germany. For further information about visa and passport please contact the German embassy in your country. If an invitation letter for visa purposes is required please contact MedConcept. Abstracts Deadline Abstract Submission: May 30, 2011 Abstracts will be considered for Poster Presentation as part of the Poster Discussion Sessions. Selected abstracts will be chosen for an oral presentation during the Free Communications Sessions. Please visit for further information. Congress organisation by: MedConcept Gesellschaft für medizinische Projekte mbh August-Borsig-Ring Schöneiche bei Berlin Phone Fax info@medconcept.org

16 REGISTRATION FORM July 7th 8th, 2011 European PostASCO Meeting 2011 Interdisciplinary Global Conference on Developing New Treatments for Melanoma First Name: Last Name: Professional Title: Degree: MD PhD RN PA-C Other Gender: Male Female Birth Date (YY/MM/DD) Speciality: Institution: Mailing address: City: State: Zip Code: Country: Daytime Telephone: Fax: Fees (VAT included) Early registration: till May 6 th From May 7 th till June 24 th On site Full Delegates 300 Euro 400 Euro 500 Euro Residents (doctor-in-training) 200 Euro 250 Euro 300 Euro Eastern European Countries 200 Euro 250 Euro 300 Euro Day Ticket July 7 th July 8 th 150 Euro 200 Euro 250 Euro If more than one member of the same institution registers a special early registration fee of 250 Euro per person (Full Delegates) and 150 Euro per person (Residents and Eastern European Countries) will be honored for all participants belonging to this institution. This offer is only valid if participants can proof that multiple members of this institution have registered. No. of acc. persons: names: No. of Tickets for Get-Together-Dinner, July 7th, Beer Garden (50 Euro): Total Amount (registration fee/dinner): Euro Payment Method Invoice: Credit Card: MasterCard Visa American Express Credit Card Number: Expiration Date: Security Code CCV: (MC/Visa 3 digits on back, AMEX 4 digits on front) Cardholder Name: Signature: To Register Mail Registration form and payment to: MedConcept GmbH, August-Borsig-Ring 37, Schöneiche bei Berlin, Germany Fax Registration to: Register online: For more information: Please contact Mirja Christ info@medconcept.org MedConcept Gesellschaft für medizinische Projekte mbh

17 sponsors Gold Bronze Philogen innovating targeting Further Sponsors AB Science BioVex Celgene DCS Innovative Diagnostik-Systeme Delcath Systems IGEA S.p.A. Lilly Deutschland medac Spirig Pharma Vical Incorporated Viralytics

18 Erdgeschoss/Ground Floor Terrasse/terrace R6 R7 R5 R4 Speaker- Preview- Room R3 R2 R1 Service Terrasse/terrace Service künstlicher Wasserlauf/ artificial water point Foyer Business Center Einfahrt Tiefgarage/ access underground parking WC/ toilet Davidoff Lounge Lifts Registration Desk Lobby Reception Desk Back Office Moosacher Straße 90 Hoteleingang/ hotel entrance Leonardo Royal Hotel Munich Untergeschoss/Basement